Astera Labs, Inc. (ALAB) EBITDA
- 2026-06-30: Basis Reported; EBITDA $93.15M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA $65.53M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $56.91M; Operating income (m); Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA $41.17M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2024-03-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | $93.15M | (m) | (m) | (m) | (m) | $20.47M* | $87.68M* | $104.83M | $135.90M | (m) | -$50.26M |
|---|
| 2026-03-31 | Reported | $65.53M | (m) | (m) | (m) | (m) | $7.59M | $74.60M | $73.22M | $125.63M | (m) | -$6.90M |
|---|
| 2025-09-30 | Reported | $56.91M | (m) | (m) | (m) | (m) | $12.29M* | $78.17M* | $54.76M | $78.93M | (m) | -$24.25M |
|---|
| 2025-06-30 | Reported | $41.17M | (m) | (m) | (m) | (m) | $2.02M* | $135.37M* | $46.36M | $66.72M | (m) | -$560.00K |
|---|
| 2025-03-31 | Reported | $12.39M | (m) | (m) | (m) | (m) | $4.54M | $10.50M | $40.03M | $64.55M | (m) | -$10.10M |
|---|
| 2024-09-30 | Reported | -$8.1M | (m) | (m) | (m) | (m) | $16.70M* | $63.51M* | $25.21M | $50.66M | (m) | $9.61M |
|---|
| 2024-06-30 | Reported | -$23.65M | (m) | (m) | (m) | (m) | -$1.32M* | $29.81M* | $17.00M | $40.09M | (m) | -$6.54M |
|---|
| 2024-03-31 | Reported | -$82.35M | (m) | (m) | (m) | (m) | $3.42M | $3.65M | $14.74M | $53.56M | (m) | $12.58M |
|---|
| 2023-09-30 | Reported | (m) | -$1.98M | (m) | $36.93M | (m) | $736.00K* | -$334.00K* | $8.82M | $20.63M | (m) | $2.87M |
|---|
| 2023-06-30 | Reported | (m) | -$17.61M | (m) | $10.69M | (m) | $575.00K* | -$22.96M* | $2.25M | $17.86M | (m) | $3.95M |
|---|
| 2023-03-31 | Reported | (m) | -$18.93M | (m) | $17.66M | (m) | $439.00K | -$3.82M | $13.41M | $15.27M | (m) | $123.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | $173.42M | (m) | $852.52M | (m) | $37.54M | $319.31M | $207.26M | $304.00M | (m) | -$981.00K |
|---|
| 2024-12-31 | Reported | (m) | -$116.07M | (m) | $396.29M | (m) | $34.24M | $136.68M | $93.59M | $200.83M | (m) | $1.64M |
|---|
| 2023-12-31 | Reported | (m) | -$29.50M | (m) | $115.79M | (m) | $2.76M | -$12.72M | $35.97M | $73.41M | (m) | $3.31M |
|---|
| 2022-12-31 | Reported | (m) | -$60.19M | (m) | $79.87M | (m) | $3.87M | -$35.90M | $21.19M | $73.71M | (m) | $764.00K |
|---|